| Pharmaceutical Information |
| Drug Name |
Tocophersolan |
| Drug ID |
BADD_D02235 |
| Description |
D-Alpha-tocopheryl polyethylene glycol 1000 succinate (Tocofersolan, Vedrop), has been developed in Europe as an orally bioavailable source of vitamin E in children suffering from cholestasis [L2371]. Cholestasis is the reduction or stoppage of bile flow, either to impaired secretion by _hepatocytes_ (liver cells) or obstruction [L2374], [L2375].
Tocofersolan is a polyethylene glycol derivative of α-tocopherol and synthetic water-soluble version of [DB11251]. Tocofersolan is an oral treatment of vitamin E deficiency due to digestive malabsorption in pediatric patients with congenital chronic cholestasis or hereditary chronic cholestasis. It was approved by the European Medicines Agency (EMA) in June 2009 under the market name Vedrop. Moreover, the agent is capable of demonstrating antioxidant effects that make it a popular component to include in cosmetics and pharmaceuticals as well.
In addition to the above, tocofersolan has been studied as a promising application as an absorption enhancer in drug delivery [MSDS]. |
| Indications and Usage |
Tocofersolan is indicated in vitamin E deficiency caused by digestive malabsorption in pediatric patients with congenital chronic cholestasis or hereditary chronic cholestasis from birth (full term newborns) up to 18 years of age [L2371]. |
| Marketing Status |
approved |
| ATC Code |
A11HA08 |
| DrugBank ID |
DB11635
|
| KEGG ID |
D06174
|
| MeSH ID |
C014225
|
| PubChem ID |
71406
|
| TTD Drug ID |
D08CVC
|
| NDC Product Code |
Not Available |
| UNII |
Not Available
|
| Synonyms |
tocophersolan | mono-(2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanyl) succinate polyethylene glycol monoester | poly(oxy-1,2-ethanediyl), alpha-(4-((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)-1,4-dioxobutyl-omega-hydroxy- | tocofersolan | tocopherol polyethylene glycol succinate | vitamin E-TPGS | TPGS | vitamine E PEG-1000-succinate | alpha-tocopheryl polyethylene glycol succinate | (+)-alpha-tocopheryl polyethylene glycol 1000 succinate | tocopheryl poly(ethylene glycol) 1000 succinate | tocophersolan, (2R-(2R*(4R*,8R*)))-isomer | tocopherol poly(ethylene glycol) 2000 succinate | alpha-D-tocopherol poly(ethylene glycol) 2000 succinate | TPGS 2K |
|
| Chemical Information |
| Molecular Formula |
C35H58O6 |
| CAS Registry Number |
30999-06-5 |
| SMILES |
CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
